Trade Vir Biotechnology VIR

Sell
 Buy

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Oct 03, 15:22

Vir Biotechnology (VIR) Could Be 48% Undervalued Following Its CFO Appointment

Vir Biotechnology Inc
Webhose 2026 Sep 30, 08:14

Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages

Vir Biotechnology Inc
Webhose 2026 Sep 26, 07:38

Bank of America Corp DE Acquires 1,142,539 Shares of Vir Biotechnology, Inc. $VIR

Vir Biotechnology Inc
Webhose 2026 Sep 15, 04:45

Reviewing Tango Therapeutics (NASDAQ:TNGX) and Vir Biotechnology (NASDAQ:VIR) - Stock Observer

Vir Biotechnology Inc

VirBiotechnology News

Julian Parker 2026 Sep 29, 16:05

GBP/USD Forecast: Can Sterling Hold 1.32 as Fed Rate-Hike Bets Rise?

forex
aud-usd
Julian Parker 2026 Sep 28, 16:04

AUD to USD Forecast 2026–2030: Can the Aussie Reclaim 0.71 After the RBA’s Fourth Rate Hike?

forex
usd-cad
Julian Parker 2026 Sep 27, 16:04

USD/CAD Forecast 2026–2030: Can Fed–BoC Rate Divergence Push the Pair Above 1.42?

forex
2026 Sep 27, 16:00

PCE+GDP: A Double Data Shock Could Move Markets

Julian Parker 2026 Sep 23, 16:04

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

stocks
is spacex a good stock to buy
Daniel Carter 2026 Sep 13, 16:03

Is SpaceX a Good Stock to Buy in 2026?

best gold stock to buy
Daniel Carter 2026 Sep 07, 16:02

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

advanced cfd trading tools review
Daniel Carter 2026 Aug 30, 16:02

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

gold price trend 2024 to 2026 analysis facts
Daniel Carter 2026 Aug 24, 16:03

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

upcoming ipos 2026
Daniel Carter 2026 Aug 24, 16:03

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

Latest news

Show more
Julian Parker 2026 Sep 29, 16:06

Micron Q4 Earnings Preview: AI Memory Demand Sets High Bar for MU Stock

Stock
nonfarm payrolls
Julian Parker 2026 Sep 29, 16:05

NFP Preview: US Jobs Report to Test Fed Rate-Hike Expectations

oil
Julian Parker 2026 Sep 29, 16:05

Brent Eases as Gulf Exports Recover and US Offers Reserve Oil

Commodities
gold-trading
Julian Parker 2026 Sep 29, 16:04

Gold Price Today: Gold Steadies Near $4,180 After Sharp Selloff

gold price today
meta stock news today
Julian Parker 2026 Sep 29, 16:03

Meta Stock Rises 3.24% as Muse Enterprise AI Push Gains Momentum

Stock
amd-stock
Julian Parker 2026 Sep 28, 16:06

AMD Stock Falls 3.6% as Oil and Treasury Yields Rise; $8.2 Billion World Labs Deal Announced After Close

Stock
nasdaq price today
Julian Parker 2026 Sep 28, 16:06

US Stocks Fall as Dow Drops 347 Points; Chip Shares Slide Despite Nvidia Buyback

Stock
nvidia-stock
Julian Parker 2026 Sep 28, 16:04

Nvidia Stock Rises as Record $150 Billion Buyback Defies Chip Selloff

Stock

Info

Spread

0.13

Spread (%)

1.1712 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1890142208

Shares Outstanding

169215958

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.77

Learn more about this instrument

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
How to Trade NFP
Julian Parker 2026 Sep 28, 16:05

How to Trade NFP: Read the Jobs Report and Manage Risk

Julian Parker 2026 Sep 23, 13:00

Risk Management 101

best-ai-stocks
Julian Parker 2026 Sep 22, 16:05

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

stock
Trustpilot